Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Team Grant: DM/TS - CIHR-JDRF - ß-cell and Pancreatic Islet Physiology - LOI

Sunnybrook Research Institute (Toronto, Ontario)

$10,000.00

Regenerating Human Pancreatic Beta Cells to Treat Diabetes

EF 2020-21

Résumé
Our vision is to establish a complete understanding of the biology of human beta cells, the cells that make and secrete insulin after a meal. The inability to produce enough insulin results in diabetes mellitus (DM), and affects over 13M Canadians. While it is widely held that treating DM will require improving the health of the human beta cell, our current knowledge of the basic properties of the human beta cell are lacking. We will use cutting-edge genetic technology to provide a complete understanding of how both mature adult human beta cells and their stem cell precursors grow, divide and secrete insulin. Furthermore, we will explore targeting a novel pathway we discovered that when activated helps to increase beta cell function in response to high sugar levels and promotes beta cell proliferation for prevention and treatment of DM.
Programme
Team Grant: DM/TS - CIHR-JDRF - ß-cell and Pancreatic Islet Physiology - LOI
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
446712
Name
Screaton Robert A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Team Grant: Diabetes Mechanisms and Translational Solutions - LOI
Projecttitle
Regenerating Human Pancreatic Beta Cells to Treat Diabetes
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Team Grant: DM/TS - CIHR-JDRF - ß-cell and Pancreatic Islet Physiology - LOI
Keyworddelim
Animal Models; Beta Cells; Cell Cycle; Crispr; Diabetes; G Protein Coupled Receptors; Human Es Cells; Incretins; Islets; Rnai
Abstract
Our vision is to establish a complete understanding of the biology of human beta cells, the cells that make and secrete insulin after a meal. The inability to produce enough insulin results in diabetes mellitus (DM), and affects over 13M Canadians. While it is widely held that treating DM will require improving the health of the human beta cell, our current knowledge of the basic properties of the human beta cell are lacking. We will use cutting-edge genetic technology to provide a complete understanding of how both mature adult human beta cells and their stem cell precursors grow, divide and secrete insulin. Furthermore, we will explore targeting a novel pathway we discovered that when activated helps to increase beta cell function in response to high sugar levels and promotes beta cell proliferation for prevention and treatment of DM.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Screaton, Robert A; Lim, Gareth E; Lynn, Francis C; Mulvihill, Erin E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~